Thymosin β4 promotes angiogenesis and increases muscle progenitor cell density in ischemic skeletal muscle in a mouse model of hind limb ischemia

Yue Zhou, Eliana C. Martinez, Li-Ping Su, Kok-Onn Lee, Lei Ye

Department of Medicine, National University of Singapore, Singapore, Minnesota, USA.
Department of Medicine, National University of Singapore, Singapore, Minnesota, USA..
Department of Medicine, University of Minnesota, Minnesota, USA.
Department of Surgery, National University of Singapore, Singapore, Minnesota, USA.
Division of Bioengineering, National University of Singapore, Singapore, Minnesota, USA.

DOI: 10.4236/ojrm.2012.12003                

Abstract

Aim: To determine the therapeutic effect of thy- mosin β4 (Tβ4) for treatment of ischemic limb disease in a mouse model. Methods: A mouse model of hindlimb ischemia was created by permanent ligation of femoral arteries and internal iliac artery. Tβ4 was dissolved in sterile saline and intramuscularly injected into the centre and periphery of ligation area in the treatment group (n = 10) starting from the surgery day until 4 weeks after surgery, while control animals received saline injection only (n = 9). All animals were sacrificed at 6 weeks after surgery and used for immunohistochemistry studies. Results: Tβ4 stimulated angiogenesis was evidenced by increased vascular density based on CD31 immunostaining, which was sig- nifycantly increased in Tβ4 group (562.5 ± 78.4/mm2) as compared with control group (371.1 ± 125.7/mm2; p < 0.05). The arteriole density based on CD31 and SMA dual immunostaining was similar between the Tβ4 (27.2 ± 16.9/mm2) and control (35.3 ± 6/mm2; p > 0.05) groups. Tβ4 increased Pax3/7+ skeletal muscle progenitor cell density. Pax3/7+ cell density of Tβ4 group (13.7% ± 2%) was significantly higher than that of the control group (4.3% ± 1.6%, p < 0.05). However, the numbers of central nuclei fiber and central nuclei per fiber were insignificantly increased in Tβ4 group as compared to control group. The numbers of central nuclei fiber were 8.9 ± 2.1 and 9.5 ± 1.6, and the central nuclei per fiber were 0.25 ± 0.07 and 0.48 ± 0.09 for control and Tβ4 groups, respectively. Conclusions: This preliminary study suggests that localized delivery of Tβ4 increased angiogenesis and skeletal muscle progenitor cell density in ischemic skeletal muscle, but failed to promote skeletal muscle regeneration.

Keywords

Thymosin β4; Neovascularization;Progenitor Cell; Muscle Regeneration

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Pollard, T.D. and Borisy, G.G. (2003) Cellular motility driven by assembly and disassembly of actin filaments. Cell, 112, 453-465. doi:10.1016/S0092-8674(03)00120-X
[2]	Bock-Marquette, I., et al. (2004) Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 432, 466-472. doi:10.1038/nature03000
[3]	Yang, H., et al. (2008) The promotive effects of thymosin β4 on neuronal survival and neurite outgrowth by up- regulating L1 expression. Neurochemical Research, 33, 2269-2280. doi:10.1007/s11064-008-9712-y
[4]	Philp, D., et al. (2004) Thymosin β4 increases hair grow- th by activation of hair follicle stem cells. The FASEB Journal, 18, 385-387.
[5]	Philp, D., Scheremeta, B., Sibliss, K., Zhou, M., Fine, E.L., Nguyen, M., et al. (2006) Thymosin β4 promotes matrix metalloproteinase expression during wound repair. Journal of Cellular Physiology, 208, 195-200. doi:10.1002/jcp.20650
[6]	Sosne, G., et al. (2005) Thymosin β4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Investigative Ophthalmology & Visual Science, 46, 2388-2395. doi:10.1167/iovs.04-1368
[7]	Qiu, P., et al. (2011) Thymosin β4 inhibits TNF-alpha- induced NF-κB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. The FASEB Journal, 25, 1815-1826. doi:10.1096/fj.10-167940
[8]	Sosne, G., et al. (2005) Thymosin β4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Investigative Ophthalmology & Visual Science, 46, 2388-2395. doi:10.1167/iovs.04-1368
[9]	Ferre, P.J., et al. (2007) Longitudinal analysis of gene ex- pression in porcine skeletal muscle after post-injection local injury. Pharmaceutical Research, 24, 1480-1489. doi:10.1007/s11095-007-9266-8
[10]	Ye, L., Su, L.P., Pi, W.F. and Law, P.K. (2012) Role of thymosin β4 on skeletal myoblast migration, proliferation, and survival. Recent Patents on Regenerative Medicine, 2, 146-155. doi:10.2174/2210297311202020146
[11]	Ye, L., et al. (2010) Liposome-based vascular endothelial growth factor-165 transfection with skeletal myoblast for treatment of ischaemic limb disease. Journal of Cellular and Molecular Medicine, 14, 323-336. doi:10.1111/j.1582-4934.2008.00454.x
[12]	Smart, N., et al. (2007) Thymosin β4 is essential for coronary vessel development and promotes neovascularization via adult epicardium. Annals of the New York Academy of Science, 1112, 171-188. doi:10.1196/annals.1415.000
[13]	Malinda, K.M., Goldstein, A.L. and Kleinman, H.K. (1997) Thymosin β4 stimulates directional migration of human umbilical vein endothelial cells. The FASEB Jour- nal, 11, 474-481.
[14]	Chiu, L.L. and Radisic, M. (2011) Controlled release of thymosin β4 using collagen-chitosan composite hydrogels promotes epicardial cell migration and angiogenesis. Journal of Controlled Release, 155, 376-385. doi:10.1016/j.jconrel.2011.05.026
[15]	Grant, D.S., et al. (1999) Thymosin β4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis, 3, 125-135. doi:10.1023/A:1009041911493
[16]	Qiu, F.Y., et al. (2009) Thymosin β4 induces endothelial progenitor cell migration via PI3K/Akt/eNOS signal transduction pathway. Journal of Cardiovascular Pharmacology, 53, 209-214. doi:10.1097/FJC.0b013e318199f326
[17]	Kassar-Duchossoy, L., et al. (2005) Pax3/Pax7 mark a novel population of primitive myogenic cells during development. Genes & Development, 19, 1426-1431. doi:10.1101/gad.345505
[18]	Relaix, F., et al. (2005) A Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature, 435, 948- 953. doi:10.1038/nature03594
[19]	Maroto, M., et al. (1997) Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell, 89, 139-148. doi:10.1016/S0092-8674(00)80190-7
[20]	Kuang, S., et al. (2006) Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. Journal of Cell Biology, 172, 103-113. doi:10.1083/jcb.200508001
[21]	Relaix, F., et al. (2006) Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. Journal of Cell Biology, 172, 91-102. doi:10.1083/jcb.200508044
[22]	Spurney, C.F., et al. (2010) Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin β4 in the dystrophin deficient mouse. PLOS One, 5, p. e8976. doi:10.1371/journal.pone.0008976